The results highlight the importance of evaluating and monitoring cognitive function in individuals with recent critical illness or major infections, especially if they are already at risk for dementia.
The FDA has taken action against 17 companies that are illegally selling unapproved and/or misbranded products that claim to prevent, treat, or cure Alzheimer disease and other serious diseases and health conditions.
In the United Kingdom, patients from minority ethnic groups have lower cognitive scores and are younger at first diagnosis of dementia than the white UK-born population.
Treating systolic blood pressure to a goal of less than 120 mm Hg rather than 140 mm Hg does not result in a significant reduction in the risk for probable dementia.
Crenezumab is an investigational monoclonal antibody that preferentially binds to and promotes the removal of neurotoxic oligomers, a form of beta-amyloid.
Algorithms that combine Internet of Things technologies and in-home sensory devices with machine learning techniques can be used to monitor the health and well-being of people with dementia.
